[The Association of Urological Oncology (AOU) German Cancer Society e.V. The competent counterpart for research in Uro-oncology].
With more than 85,000 newly diagnosed cancers per year, uro-oncology alone represents a significant part in the field of oncology in Germany. Therefore, the Task Group for Uro-Oncology (The Association of Urogenital Oncology, AUO) of the German Cancer Association (DKG) was founded in 1989 to enforce high quality in research on urological cancer. The main aim has been to improve the quality of clinical cancer studies. The board of the AUO reviews, certifies and gives accreditation to study protocols with respect to GCP standards, likelihood of realisation and scientific impact of the study objectives. To support enrolment of patients, the AUO initiated a study group of more than 85 clinical centers of excellence and publishes timely details on the different studies in the appropriate media. Moreover, the members of the AUO board organize seminars, scientific meetings and pharmaceutical hearings. In this article, the organisation's structure is described in detail. Various aspects of AUO work, carried out over the years, are highlighted, and data presented on the outcome of studies.
Rexer
H
H
auo@meckevidence.de
D035843:Biomedical Research / Q000458:organization & administration* / Q000592:standards; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D005858:Germany; D008495:Medical Oncology / Q000458:organization & administration* / Q000592:standards; D012106:Research / Q000458:organization & administration* / Q000592:standards; D012955:Societies, Medical / Q000458:organization & administration* / Q000592:standards; D014565:Urogenital Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D014572:Urology / Q000458:organization & administration* / Q000592:standards